News and Announcements
OncoSil Medical to Attend 48th European Pancreatic Club Meeting
- Published July 07, 2016 9:44AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
6th July 2017, ASX Announcement
OncoSil Medical Limited (ASX:OSL) (OncoSil Medical or the Company) a late stage medical device company focused on localised treatments for patients with pancreatic and liver cancer, today announced that a team of senior management would be attending the 48th European Pancreatic Club (EPC) in Liverpool, England.
The European Pancreatic Club meeting hosted by EPC President, Professor John Neoptolemos is focused entirely on pancreatic diseases and pancreatic cancer, making it one of the key international Scientific meetings for the Company to attend. This year the EPC meeting will run form 6 to 9 July 2016 and will host over 80 invited speakers from across Europe, the United States, Asia and Australia.
To view the full announcement, please click on the button below.